Malini Ravi

496 total citations
10 papers, 416 citations indexed

About

Malini Ravi is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Malini Ravi has authored 10 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Malini Ravi's work include Quinazolinone synthesis and applications (4 papers), HER2/EGFR in Cancer Research (3 papers) and Synthesis and biological activity (2 papers). Malini Ravi is often cited by papers focused on Quinazolinone synthesis and applications (4 papers), HER2/EGFR in Cancer Research (3 papers) and Synthesis and biological activity (2 papers). Malini Ravi collaborates with scholars based in United States, Brazil and Canada. Malini Ravi's co-authors include A. J. Hopfinger, M. Brawner Floyd, Robert E. Hormann, Laurence Dinan, Kristina M. K. Kutterer, Hwei‐Ru Tsou, Frank Loganzo, Gary H. Birnberg, Arie Zask and Allan Wissner and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Malini Ravi

10 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malini Ravi United States 10 231 178 77 74 31 10 416
Dan M. Berger United States 11 248 1.1× 184 1.0× 50 0.6× 92 1.2× 22 0.7× 13 395
Chinatsu Ikeura Japan 7 246 1.1× 146 0.8× 54 0.7× 100 1.4× 36 1.2× 9 397
Yoshiaki Washio United Kingdom 8 215 0.9× 192 1.1× 51 0.7× 50 0.7× 12 0.4× 11 373
Manolis A. Fousteris Greece 16 341 1.5× 273 1.5× 39 0.5× 97 1.3× 21 0.7× 40 590
Sotiris S. Nikolaropoulos Greece 16 328 1.4× 336 1.9× 57 0.7× 105 1.4× 20 0.6× 49 637
Ola I. A. Salem Egypt 14 418 1.8× 217 1.2× 58 0.8× 76 1.0× 35 1.1× 26 586
Jenny Roy Canada 17 250 1.1× 333 1.9× 74 1.0× 123 1.7× 55 1.8× 61 790
Lan Shen United States 12 282 1.2× 241 1.4× 34 0.4× 68 0.9× 19 0.6× 23 532
Yasmin M. Syam Egypt 13 383 1.7× 184 1.0× 83 1.1× 80 1.1× 23 0.7× 25 527
Michiko Tawada Japan 11 185 0.8× 219 1.2× 45 0.6× 79 1.1× 8 0.3× 19 422

Countries citing papers authored by Malini Ravi

Since Specialization
Citations

This map shows the geographic impact of Malini Ravi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malini Ravi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malini Ravi more than expected).

Fields of papers citing papers by Malini Ravi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malini Ravi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malini Ravi. The network helps show where Malini Ravi may publish in the future.

Co-authorship network of co-authors of Malini Ravi

This figure shows the co-authorship network connecting the top 25 collaborators of Malini Ravi. A scholar is included among the top collaborators of Malini Ravi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malini Ravi. Malini Ravi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tsou, Hwei‐Ru, Xiaoxiang Liu, Gary H. Birnberg, et al.. (2009). Discovery of 4-(Benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(Pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4. Journal of Medicinal Chemistry. 52(8). 2289–2310. 64 indexed citations
2.
Mayer, Scott C., Frank Boschelli, Li Di, et al.. (2008). Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Bioorganic & Medicinal Chemistry Letters. 18(12). 3641–3645. 60 indexed citations
3.
Tsou, Hwei‐Ru, M. Brawner Floyd, Marvin F. Reich, et al.. (2008). 4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4 (CDK4). Journal of Medicinal Chemistry. 51(12). 3507–3525. 55 indexed citations
4.
Wissner, Allan, Russell G. Dushin, M. Brawner Floyd, et al.. (2007). Dual irreversible kinase inhibitors: Quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2. Bioorganic & Medicinal Chemistry. 15(11). 3635–3648. 62 indexed citations
5.
Romeiro, Nelilma Correia, Magaly Girão Albuquerque, Ricardo Bicca de Alencastro, Malini Ravi, & A. J. Hopfinger. (2006). Free-energy force-field three-dimensional quantitative structure–activity relationship analysis of a set of p38-mitogen activated protein kinase inhibitors. Journal of Molecular Modeling. 12(6). 855–868. 9 indexed citations
6.
Romeiro, Nelilma Correia, Magaly Girão Albuquerque, Ricardo Bicca de Alencastro, Malini Ravi, & A. J. Hopfinger. (2005). Construction of 4D-QSAR Models for Use in the Design of Novel p38-MAPK Inhibitors. Journal of Computer-Aided Molecular Design. 19(6). 385–400. 31 indexed citations
7.
Ravi, Malini, Arie Zask, & Thomas S. Rush. (2005). Structure-Based Identification of the Binding Site for the Hemiasterlin Analogue HTI-286 on Tubulin. Biochemistry. 44(48). 15871–15879. 17 indexed citations
8.
Berger, Dan M., Minu Dutia, Gary H. Birnberg, et al.. (2005). 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as Potent Src Kinase Inhibitors. Journal of Medicinal Chemistry. 48(19). 5909–5920. 13 indexed citations
9.
Wissner, Allan, M. Brawner Floyd, Bernard D. Johnson, et al.. (2005). 2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as Covalent-Binding, Irreversible Inhibitors of the Kinase Domain of Vascular Endothelial Growth Factor Receptor-2. Journal of Medicinal Chemistry. 48(24). 7560–7581. 55 indexed citations
10.
Ravi, Malini, A. J. Hopfinger, Robert E. Hormann, & Laurence Dinan. (2001). 4D-QSAR Analysis of a Set of Ecdysteroids and a Comparison to CoMFA Modeling. Journal of Chemical Information and Computer Sciences. 41(6). 1587–1604. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dan M. Berger Breakdown of academic impact, for papers by Chinatsu Ikeura Breakdown of academic impact, for papers by Yoshiaki Washio Breakdown of academic impact, for papers by Manolis A. Fousteris Breakdown of academic impact, for papers by Sotiris S. Nikolaropoulos Breakdown of academic impact, for papers by Ola I. A. Salem Breakdown of academic impact, for papers by Jenny Roy Breakdown of academic impact, for papers by Lan Shen Breakdown of academic impact, for papers by Yasmin M. Syam Breakdown of academic impact, for papers by Michiko Tawada
Rankless by CCL
2026